Who founded Pathalys?

Pathalys was founded by BT Slingsby in 2021.

Who are Pathalys's investors?

Pathalys's investors include Abingworth, Catalys Pacific, OrbiMed, Samsara BioCapital, KB Investment.

Pathalys is headquartered in Research Triangle Park, US.

Research Triangle Park, US · Founded 2021 · 18 employees on LinkedIn · 7 known investors

Pathalys Pharma is a biotechnology company developing and improving therapeutic treatments for patients with chronic kidney disease.

Pathalys was founded in 2021 by BT Slingsby.

BT SlingsbyinCo-Founder & Executive Chairman

J.P. Morgan Life Sciences Private CapitalTCGXlead

SEC filings, press & company announcements

Undisclosed amountseries BAug 2024
TCGX (lead), J.P. Morgan Life Sciences Private Capital, KB Investment, Marshall Wace, Samsara BioCapital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

2 people who came through Pathalys went on to found or lead other companies.

What does Pathalys do?: Pathalys Pharma is a biotechnology company developing and improving therapeutic treatments for patients with chronic kidney disease.
Who founded Pathalys?: Pathalys was founded by BT Slingsby in 2021.
Who are Pathalys's investors?: Pathalys's investors include Abingworth, Catalys Pacific, OrbiMed, Samsara BioCapital, KB Investment.
Where is Pathalys headquartered?: Pathalys is headquartered in Research Triangle Park, US.